Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 540596 | NSE: ERIS

Watchlist

NSE BSE

1011.95

05-Jul-2024

Open
High
Low
Previous Close

1034.00
1047.35
1007.10
1030.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

110955
1137.86
1522.05
809.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,730.20
53.55
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

21,218.92
N/A
6.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.92
13.34
14.26

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.71
12.90
6.83

PAT CAGR (%)

10 Years
5 Years
3 Years

15.95
5.74
-1.17

P:E (Median)

8 Years
5 Years
3 Years

-
24.29
25.43

P:BV (Average)

8 Years
5 Years
3 Years

-
5.14
5.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
19.23
19.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 436.56 409.71 6.55% 456.69 411.29 11.04% 341.30 314.58 8.49% 324.41 332.01 -2.29%
Expenses 293.93 265.22 10.82% 333.31 255.78 30.31% 261.91 203.09 28.96% 249.98 205.62 21.57%
EBITDA 142.63 144.49 -1.29% 123.38 155.51 -20.66% 79.39 111.49 -28.79% 74.43 126.39 -41.11%
EBIDTM 32.67% 35.27% 27.02% 37.81% 23.26% 35.44% 22.94% 38.07%
Other Income 5.81 6.98 -16.76% 5.16 4.03 28.04% 20.39 4.26 378.64% 3.43 3.48 -1.44%
Interest 56.26 6.55 758.93% 56.17 6.84 721.20% 28.89 2.96 876.01% 15.14 3.14 382.17%
Depreciation 46.16 25.00 84.64% 45.55 20.16 125.94% 29.14 17.28 68.63% 28.08 16.50 70.18%
PBT 46.02 119.92 -61.62% 26.82 132.54 -79.76% 41.75 95.51 -56.29% 34.64 110.23 -68.57%
Tax 17.92 2.11 749.29% 9.78 21.78 -55.10% 2.24 7.67 -70.80% 2.99 10.85 -72.44%
PAT 28.10 117.81 -76.15% 17.04 110.76 -84.62% 39.51 87.84 -55.02% 31.66 99.38 -68.14%
PATM 6.44% 28.75% 3.73% 26.93% 11.58% 27.92% 9.76% 29.93%
EPS 2.06 8.66 -76.21% 1.25 8.14 -84.64% 2.90 6.45 -55.04% 2.33 7.30 -68.08%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 741.17 505.30 46.68% 719.72 466.62 54.24% 550.92 402.80 36.77% 486.30 423.26 14.89%
Expenses 476.66 324.16 47.04% 469.73 296.87 58.23% 402.49 283.90 41.77% 310.79 286.06 8.65%
EBITDA 264.51 181.14 46.03% 249.99 169.75 47.27% 148.43 118.89 24.85% 175.51 137.20 27.92%
EBIDTM 35.69% 35.85% 34.73% 36.38% 26.94% 29.52% 36.09% 32.42%
Other Income 4.55 3.48 30.75% 1.64 0.99 65.66% 15.15 1.00 1,415.00% 4.20 2.24 87.50%
Interest 59.47 16.30 264.85% 60.37 17.36 247.75% 33.03 8.87 272.38% 18.12 3.00 504.00%
Depreciation 80.48 42.09 91.21% 75.94 40.89 85.72% 53.90 35.13 53.43% 45.72 29.90 52.91%
PBT 129.11 126.23 2.28% 115.32 112.49 2.52% 76.65 75.90 0.99% 115.87 106.54 8.76%
Tax 32.76 3.93 733.59% 25.90 18.84 37.47% -2.99 14.42 - 14.41 6.31 128.37%
PAT 96.35 122.30 -21.22% 89.42 93.65 -4.52% 79.63 61.48 29.52% 101.46 100.23 1.23%
PATM 13.00% 24.20% 12.42% 20.07% 14.45% 15.26% 20.86% 23.68%
EPS 6.73 9.08 -25.88% 6.11 6.97 -12.34% 5.22 4.81 8.52% 7.55 7.49 0.80%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,558.96 1,486.71 1,330.72 1,215.73 1,108.83 1,020.23 896.54 760.60 712.90 605.48 547.99 Net Sales Growth 6.23% 11.72% 9.46% 9.64% 8.68% 13.80% 17.87% 6.69% 17.74% 10.49% Cost Of Goods Sold 385.79 280.16 236.38 199.65 198.51 164.35 132.35 115.94 135.66 116.14 114.22 Gross Profit 1,173.17 1,206.54 1,094.34 1,016.08 910.32 855.88 764.19 644.67 577.24 489.33 433.76 GP Margin 75.25% 81.16% 82.24% 83.58% 82.10% 83.89% 85.24% 84.76% 80.97% 80.82% 79.15% Total Expenditure 1,139.13 1,032.89 825.61 731.67 691.36 665.28 562.77 444.67 441.70 435.01 434.13 Power & Fuel Cost - 4.46 4.41 4.01 3.89 4.54 3.34 3.04 2.93 2.74 4.13 % Of Sales - 0.30% 0.33% 0.33% 0.35% 0.44% 0.37% 0.40% 0.41% 0.45% 0.75% Employee Cost - 331.67 252.52 220.11 207.02 191.73 166.77 130.84 116.31 122.36 123.75 % Of Sales - 22.31% 18.98% 18.11% 18.67% 18.79% 18.60% 17.20% 16.32% 20.21% 22.58% Manufacturing Exp. - 19.98 14.18 38.89 11.87 14.63 8.09 4.97 4.47 6.40 5.78 % Of Sales - 1.34% 1.07% 3.20% 1.07% 1.43% 0.90% 0.65% 0.63% 1.06% 1.05% General & Admin Exp. - 211.45 154.78 135.40 110.76 125.31 122.99 92.81 106.48 102.91 115.10 % Of Sales - 14.22% 11.63% 11.14% 9.99% 12.28% 13.72% 12.20% 14.94% 17.00% 21.00% Selling & Distn. Exp. - 140.07 137.77 98.34 109.88 131.07 125.15 95.36 72.99 82.35 70.47 % Of Sales - 9.42% 10.35% 8.09% 9.91% 12.85% 13.96% 12.54% 10.24% 13.60% 12.86% Miscellaneous Exp. - 45.10 25.57 35.28 49.43 33.64 4.09 1.71 2.85 2.10 70.47 % Of Sales - 3.03% 1.92% 2.90% 4.46% 3.30% 0.46% 0.22% 0.40% 0.35% 0.12% EBITDA 419.83 453.82 505.11 484.06 417.47 354.95 333.77 315.93 271.20 170.47 113.86 EBITDA Margin 26.93% 30.53% 37.96% 39.82% 37.65% 34.79% 37.23% 41.54% 38.04% 28.15% 20.78% Other Income 34.79 34.83 17.26 28.99 10.00 15.49 32.50 28.22 25.08 3.28 3.43 Interest 156.46 57.42 20.81 3.05 0.94 1.97 22.90 10.48 0.85 0.28 0.01 Depreciation 148.93 102.39 64.66 51.45 37.64 44.88 31.59 21.79 21.44 19.55 14.67 PBT 149.23 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 102.61 Tax 32.93 29.12 38.90 41.35 38.29 32.32 26.39 18.23 25.84 15.96 19.28 Tax Rate 22.07% 8.86% 8.90% 9.02% 9.85% 9.99% 8.46% 5.85% 9.43% 10.37% 18.79% PAT 116.31 299.71 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 83.33 PAT before Minority Interest 116.31 299.71 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 83.33 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.46% 20.16% 29.91% 34.32% 31.62% 28.55% 31.83% 38.61% 34.81% 22.79% 15.21% PAT Growth -72.03% -24.70% -4.60% 18.99% 20.37% 2.06% -2.82% 18.34% 79.85% 65.57% EPS 8.55 22.02 29.24 30.65 25.76 21.40 20.97 21.58 18.23 10.14 6.12

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,498.11 2,009.14 1,685.15 1,347.04 1,211.86 1,074.06 982.16 855.60 749.50 597.02 545.56 Net Sales Growth 38.94% 19.23% 25.10% 11.15% 12.83% 9.36% 14.79% 14.16% 25.54% 9.43% Cost Of Goods Sold 573.91 380.04 352.35 258.51 238.27 171.53 153.70 141.57 133.60 98.48 99.73 Gross Profit 1,924.20 1,629.10 1,332.80 1,088.53 973.60 902.53 828.46 714.03 615.90 498.54 445.83 GP Margin 77.03% 81.08% 79.09% 80.81% 80.34% 84.03% 84.35% 83.45% 82.17% 83.50% 81.72% Total Expenditure 1,659.67 1,334.31 1,148.40 862.01 781.11 706.17 637.08 533.49 480.36 425.32 424.10 Power & Fuel Cost - 12.04 5.70 4.16 3.95 4.62 3.45 3.17 3.02 3.59 4.89 % Of Sales - 0.60% 0.34% 0.31% 0.33% 0.43% 0.35% 0.37% 0.40% 0.60% 0.90% Employee Cost - 403.81 346.16 250.18 229.30 205.69 190.66 157.32 131.22 124.67 125.63 % Of Sales - 20.10% 20.54% 18.57% 18.92% 19.15% 19.41% 18.39% 17.51% 20.88% 23.03% Manufacturing Exp. - 23.89 15.61 38.81 11.51 13.96 7.81 4.89 5.05 7.87 6.78 % Of Sales - 1.19% 0.93% 2.88% 0.95% 1.30% 0.80% 0.57% 0.67% 1.32% 1.24% General & Admin Exp. - 253.43 206.62 154.21 121.70 135.85 142.38 116.86 121.29 104.36 115.43 % Of Sales - 12.61% 12.26% 11.45% 10.04% 12.65% 14.50% 13.66% 16.18% 17.48% 21.16% Selling & Distn. Exp. - 207.20 185.16 121.39 128.70 140.99 134.82 107.67 84.32 82.75 70.90 % Of Sales - 10.31% 10.99% 9.01% 10.62% 13.13% 13.73% 12.58% 11.25% 13.86% 13.00% Miscellaneous Exp. - 53.90 36.80 34.74 47.69 33.53 4.25 2.00 1.86 3.59 70.90 % Of Sales - 2.68% 2.18% 2.58% 3.94% 3.12% 0.43% 0.23% 0.25% 0.60% 0.14% EBITDA 838.44 674.83 536.75 485.03 430.75 367.89 345.08 322.11 269.14 171.70 121.46 EBITDA Margin 33.56% 33.59% 31.85% 36.01% 35.54% 34.25% 35.13% 37.65% 35.91% 28.76% 22.26% Other Income 25.54 23.82 11.15 26.09 8.71 16.01 31.69 26.41 25.11 3.37 3.49 Interest 170.99 84.80 26.17 4.22 1.98 2.30 23.06 10.65 1.10 0.28 0.02 Depreciation 256.04 182.60 117.09 64.70 42.98 50.26 36.35 25.64 22.76 20.36 15.51 PBT 436.95 431.24 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 109.42 Tax 70.08 34.19 30.48 36.41 39.36 34.84 26.21 17.25 23.78 19.59 20.16 Tax Rate 16.04% 7.93% 7.53% 8.23% 9.98% 10.51% 8.26% 5.52% 8.79% 12.68% 18.42% PAT 366.86 391.98 382.16 406.11 355.13 296.50 290.80 294.11 246.79 133.57 89.23 PAT before Minority Interest 348.47 397.05 374.16 405.79 355.13 296.51 291.15 294.98 246.61 134.86 89.26 Minority Interest -18.39 -5.07 8.00 0.32 0.00 -0.01 -0.35 -0.87 0.18 -1.29 -0.03 PAT Margin 14.69% 19.51% 22.68% 30.15% 29.30% 27.61% 29.61% 34.37% 32.93% 22.37% 16.36% PAT Growth -2.86% 2.57% -5.90% 14.36% 19.77% 1.96% -1.13% 19.17% 84.76% 49.69% EPS 26.96 28.80 28.08 29.84 26.09 21.79 21.37 21.61 18.13 9.81 6.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,524.02 2,221.88 1,918.56 1,575.47 1,299.70 1,156.01 868.18 574.60 305.73 267.75 Share Capital 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 0.14 Total Reserves 2,505.36 2,205.48 1,903.07 1,557.91 1,283.27 1,141.06 854.43 560.85 305.59 267.61 Non-Current Liabilities 259.98 4.22 -170.49 -161.81 -130.18 -114.05 196.33 -22.95 20.17 18.53 Secured Loans 485.94 209.47 0.00 0.00 0.00 0.00 273.69 0.00 0.00 0.50 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 40.56 31.03 28.84 29.14 24.13 16.47 15.02 19.80 23.10 19.99 Current Liabilities 2,322.54 361.73 249.79 212.42 203.06 360.46 277.88 114.26 70.81 64.30 Trade Payables 138.84 83.07 96.77 86.71 89.93 74.93 79.03 25.11 27.89 36.10 Other Current Liabilities 692.64 83.43 26.61 23.37 24.41 195.04 112.61 12.39 8.47 7.66 Short Term Borrowings 1,387.61 55.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 103.45 140.22 126.41 102.34 88.72 90.50 86.24 76.76 34.44 20.55 Total Liabilities 5,106.54 2,587.83 1,997.86 1,626.08 1,372.58 1,402.42 1,342.39 665.91 396.71 350.58 Net Block 1,515.56 897.81 642.00 584.32 600.64 483.85 489.75 91.78 64.79 61.27 Gross Block 1,811.19 1,094.83 783.40 716.88 695.65 551.80 532.93 113.20 108.20 85.52 Accumulated Depreciation 295.64 197.01 141.40 132.55 95.01 67.96 43.19 21.43 43.41 24.25 Non Current Assets 3,169.23 1,957.80 1,334.30 1,134.47 869.37 782.82 958.53 399.30 159.69 191.98 Capital Work in Progress 0.61 0.34 2.98 1.55 4.37 2.73 0.00 0.00 0.00 0.00 Non Current Investment 1,618.94 966.51 678.18 480.97 246.03 274.36 451.84 290.43 62.59 113.05 Long Term Loans & Adv. 27.05 85.95 11.13 25.36 15.44 16.00 10.95 12.19 32.30 17.66 Other Non Current Assets 7.08 7.17 0.00 42.27 2.88 5.88 6.00 4.91 0.00 0.00 Current Assets 1,937.31 630.03 663.56 491.60 503.22 619.60 383.86 266.61 237.02 158.60 Current Investments 0.00 30.00 99.55 50.40 74.27 306.11 93.76 90.18 143.73 69.24 Inventories 91.64 63.70 84.79 64.85 65.46 74.70 57.52 47.20 49.46 53.83 Sundry Debtors 239.97 229.22 137.56 113.76 140.82 75.90 60.50 41.30 25.36 23.62 Cash & Bank 1,296.74 47.65 46.10 32.66 64.95 6.47 8.81 2.06 8.53 4.91 Other Current Assets 308.97 17.47 20.97 25.70 157.71 156.42 163.28 85.87 9.94 7.00 Short Term Loans & Adv. 284.00 241.99 274.60 204.25 109.46 103.14 123.50 78.83 7.81 4.84 Net Current Assets -385.23 268.30 413.77 279.18 300.16 259.13 105.98 152.35 166.21 94.30 Total Assets 5,106.54 2,587.83 1,997.86 1,626.07 1,372.59 1,402.42 1,342.39 665.91 396.71 350.58

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,586.12 2,195.99 1,908.31 1,576.42 1,296.33 1,150.52 861.31 567.14 299.62 266.04 Share Capital 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 0.14 Total Reserves 2,567.50 2,179.59 1,892.82 1,558.87 1,279.90 1,135.57 847.56 553.39 299.49 265.91 Non-Current Liabilities 987.79 730.02 -78.80 -109.06 -79.63 -65.50 248.09 11.82 19.84 18.52 Secured Loans 654.51 644.45 45.00 0.00 0.00 0.29 274.19 0.49 0.00 0.50 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 52.72 44.67 32.16 31.47 25.98 19.39 18.71 22.96 23.10 19.99 Current Liabilities 2,608.97 521.18 283.34 235.45 220.17 377.25 293.98 129.27 68.95 65.49 Trade Payables 268.35 124.77 117.77 102.62 100.05 84.13 90.77 38.52 24.57 36.71 Other Current Liabilities 850.78 190.12 35.81 29.07 27.44 198.57 115.06 13.52 9.71 7.74 Short Term Borrowings 1,311.31 55.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 178.53 151.29 129.75 103.76 92.68 94.55 88.15 77.24 34.67 21.04 Total Liabilities 6,818.79 3,471.88 2,112.74 1,702.81 1,436.87 1,480.58 1,428.04 732.02 391.61 353.97 Net Block 4,327.52 2,568.10 917.94 853.87 874.85 760.54 771.09 231.65 71.37 71.74 Gross Block 4,781.32 2,843.17 1,091.96 1,005.79 983.89 838.26 819.52 254.43 123.31 103.73 Accumulated Depreciation 453.80 275.07 174.02 151.92 109.04 77.73 48.42 22.78 51.95 31.99 Non Current Assets 4,439.82 2,629.21 1,401.72 1,167.24 901.78 827.09 1,060.81 462.52 169.38 190.50 Capital Work in Progress 19.67 21.72 26.99 1.55 4.37 2.73 0.00 0.07 0.00 0.00 Non Current Investment 15.54 6.69 420.84 243.65 3.20 40.91 271.61 213.05 62.60 97.28 Long Term Loans & Adv. 69.65 25.32 35.94 25.90 16.47 17.03 12.11 12.84 35.41 21.48 Other Non Current Assets 7.43 7.37 0.00 42.27 2.88 5.88 6.00 4.91 0.00 0.00 Current Assets 2,378.97 842.67 711.02 535.56 535.10 653.49 367.23 269.50 222.24 163.48 Current Investments 0.00 30.01 99.55 50.40 74.78 314.94 93.76 90.18 127.44 69.24 Inventories 189.03 131.44 117.91 94.47 69.47 82.65 65.45 55.82 47.62 57.60 Sundry Debtors 422.02 292.71 160.97 140.49 156.88 83.98 66.64 48.86 25.37 23.67 Cash & Bank 1,400.63 58.46 52.33 38.28 67.33 7.51 10.64 2.42 9.69 5.72 Other Current Assets 367.28 22.42 24.04 36.24 166.63 164.41 130.74 72.22 12.11 7.25 Short Term Loans & Adv. 335.99 307.65 256.23 175.70 111.48 106.85 86.48 64.91 9.85 4.97 Net Current Assets -230.00 321.49 427.68 300.12 314.93 276.24 73.25 140.22 153.29 97.98 Total Assets 6,818.79 3,471.88 2,112.74 1,702.80 1,436.88 1,480.58 1,428.04 732.02 391.62 353.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 336.29 322.33 369.41 395.41 265.25 216.31 236.28 209.72 132.65 92.37 PBT 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 102.61 Adjustment 144.13 73.70 31.04 36.11 39.36 24.57 7.63 -0.90 17.81 11.35 Changes in Working Capital -63.19 -110.50 -37.26 38.44 -47.37 -50.18 -15.57 -11.17 -7.53 1.42 Cash after chg. in Working capital 409.77 400.11 452.31 463.44 315.59 286.17 303.95 261.92 164.21 115.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -73.48 -77.79 -82.90 -68.03 -50.34 -69.86 -67.67 -52.21 -31.55 -23.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,491.89 -513.30 -267.64 -347.86 126.74 2.08 -592.73 -198.67 -45.39 -94.36 Net Fixed Assets -716.63 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 -12.05 Net Investments -622.43 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 -84.69 Others -1,152.83 14.27 46.67 -118.38 12.06 58.55 -8.01 -19.38 1.32 2.38 Cash from Financing Activity 2,160.05 193.75 -88.42 -81.13 -333.52 -220.74 363.26 -17.52 -83.70 0.99 Net Cash Inflow / Outflow 4.45 2.78 13.36 -33.58 58.47 -2.34 6.81 -6.48 3.57 -1.00 Opening Cash & Equivalents 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91 5.90 Closing Cash & Equivalent 51.94 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 486.00 291.74 378.26 375.36 271.17 223.00 234.63 200.21 131.48 90.06 PBT 431.24 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 109.42 Adjustment 254.26 139.84 49.25 44.07 44.24 30.50 14.12 -0.65 19.92 12.15 Changes in Working Capital -98.74 -175.54 -29.90 5.33 -52.65 -53.24 -22.15 -16.45 -8.21 -8.06 Cash after chg. in Working capital 586.76 368.95 461.55 443.90 322.94 294.62 304.20 253.29 166.16 113.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -100.75 -77.21 -83.28 -68.53 -51.77 -71.63 -69.56 -53.08 -34.68 -23.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,854.52 -982.10 -319.61 -323.36 123.23 -5.05 -590.10 -184.46 -43.91 -92.13 Net Fixed Assets -716.63 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 -12.05 Net Investments -622.43 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 -84.69 Others -515.46 -454.53 -5.30 -93.88 8.55 51.42 -5.38 -5.17 2.80 4.61 Cash from Financing Activity 1,379.78 688.02 -44.70 -82.39 -334.59 -221.05 363.21 -23.66 -83.70 0.46 Net Cash Inflow / Outflow 11.26 -2.34 13.96 -30.39 59.81 -3.11 7.75 -7.91 3.87 -1.62 Opening Cash & Equivalents 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00 6.62 Closing Cash & Equivalent 94.25 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 185.18 163.18 141.00 115.74 95.51 83.97 63.14 41.79 22154.28 19402.10 ROA 7.79% 17.36% 23.02% 23.38% 20.99% 20.79% 29.24% 46.70% 36.93% 26.97% ROE 12.65% 19.25% 23.92% 24.45% 23.76% 28.21% 40.71% 56.37% 48.12% 36.85% ROCE 10.18% 20.54% 26.42% 27.12% 24.74% 25.98% 35.45% 62.40% 53.64% 45.28% Fixed Asset Turnover 1.08 1.46 1.67 1.61 1.64 1.65 2.35 6.44 6.43 7.01 Receivable days 54.81 48.81 36.56 40.89 38.77 27.76 24.43 17.07 14.34 15.05 Inventory Days 18.15 19.76 21.77 20.93 25.07 26.92 25.13 24.74 30.25 32.55 Payable days 144.56 138.85 167.72 162.39 56.42 58.45 51.57 30.40 33.54 37.94 Cash Conversion Cycle -71.60 -70.28 -109.39 -100.57 7.42 -3.77 -2.02 11.41 11.05 9.66 Total Debt/Equity 1.00 0.14 0.00 0.00 0.00 0.15 0.43 0.00 0.00 0.00 Interest Cover 6.73 22.00 151.29 416.49 165.51 14.61 30.77 321.83 556.69 0.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 189.75 161.28 140.25 115.81 95.26 83.58 62.64 41.25 21711.81 19278.55 ROA 7.72% 13.40% 21.27% 22.62% 20.33% 20.02% 27.31% 43.89% 36.17% 28.59% ROE 16.63% 18.25% 23.33% 24.78% 24.28% 28.96% 41.30% 56.90% 47.68% 40.30% ROCE 12.36% 17.30% 25.29% 27.60% 25.44% 26.54% 35.76% 62.56% 54.56% 49.25% Fixed Asset Turnover 0.55 0.90 1.33 1.25 1.18 1.18 1.59 3.97 5.42 5.68 Receivable days 61.69 46.91 39.44 43.59 40.93 27.99 24.64 18.07 14.56 15.14 Inventory Days 27.66 25.78 27.78 24.03 25.85 27.52 25.87 25.19 31.24 33.71 Payable days 188.78 125.63 155.58 155.23 59.47 59.07 54.07 32.17 33.59 41.33 Cash Conversion Cycle -99.43 -52.94 -88.36 -87.61 7.30 -3.57 -3.57 11.09 12.21 7.52 Total Debt/Equity 1.06 0.38 0.02 0.00 0.00 0.15 0.44 0.00 0.00 0.00 Interest Cover 6.09 16.46 105.81 200.75 145.25 14.76 30.31 246.14 558.56 4974.41

Top Investors:

hdfc small cap fund

lilac investments limited

uti flexi cap fund

franklin india smaller companies fund

hetal rasiklal shah

bhikhalal chimanlal shah

Annual Reports:

News Update:

Eris Lifesciences - Quarterly Results
25th Oct 2024, 13:21 PM

Read More
Eris Lifesciences acquires 100% stake in Chemman Labs
15th Oct 2024, 12:15 PM

Earlier, the company had received approval from board of directors to execute Binding Term Sheet with Chemman Labs
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback